InsidersTradesSigma
Instil Bio, Inc.: directors' dealings · United States · SEC (Form 4)
SEC:instil-bio-inc-006d41US·SEC (Form 4)Mcap 55M€Healthcare
Explore the full insider trade history of Instil Bio, Inc., a publicly traded company based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Operating in the Healthcare sector, Instil Bio, Inc. has recorded 1 reports. Market capitalisation: €54.5m. The latest transaction was disclosed on 17 March 2022 — J. Among the most active insiders: McGaughy R Kent Jr. The full history is free.
1
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
8.04 €
Analyst consensus
1 analystsHold
7.00 €Target 7.00 €(-13%)7.00 €
Income statement
Net income−71.4 M€0.0% margin
Valuation
P/Book0.5x
Balance sheet & cash
Market cap54.5 M€
Total debt85.2 M€
Free Cash Flow−46.6 M€
Debt / Equity75%
Profitability & ownership
% insiders6.3%
% institutions62.2%
Last declaration on 17 March 2022
Declarations0 total
No declarations found
0 of 0 declarations